Nomogram to Predict the Survival of Chinese Patients with Alcohol-Related Liver Disease

Figure 2

Kaplan–Meier estimate of the ALD patients stratified by cohort. AH/No ALC: patients with alcoholic hepatitis and without cirrhosis due to alcohol-related liver disease; No AH/No ALC: patients with neither alcoholic hepatitis nor cirrhosis due to alcohol-related liver disease; No AH/ALC: patients with cirrhosis due to alcohol-related liver disease and without alcoholic hepatitis; and AH/ALC: patients with both alcoholic hepatitis and cirrhosis due to alcohol-related liver disease. Kaplan–Meier curves for survival of patients with AH and without AH in the training cohort (a); Kaplan–Meier curves for survival of patients with ALC and without ALC in the training cohort (b); patients were divided into four groups, namely, AH/No ALC, No AH/No ALC, No AH/ALC, and AH/ALC. Kaplan–Meier curves for survival of the patients in the training cohort (c); Kaplan–Meier curves for survival of the patients with liver cancer and without liver cancer in the training cohort (d); Kaplan–Meier curves for survival of patients who followed abstinence and relapsed from abstinence in the training cohort (e); Kaplan–Meier curves for survival of the patients with MELD score ≥21 and with MELD <21 in the training cohort (f); Kaplan–Meier curves for survival of the patients in the training cohort and validation cohort (g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)